Inventor · disambiguated record
Tina Garyantes
Also filed as: GARYANTES TINA · GARYANTES TINA K · GARYANTES TINA KRAMER
6 granted patents·12 pending applications·404 citations·filing 1991–2024
84Inventor score
Files withLINNAEUS THERAPEUTICS INC8CHROMOCELL CORP5CHIRON DIAGNOSTICS CORP1CRYOPHARM CORP1MERCK & CO INC1
Top patents by PatentIndex Score
18 records- 0195US6565813B1Virtual wells for use in high throughput screening assaysMERCK & CO INC·Filed 1999·Granted May 20, 2003·262 cites·21 claims
- 0282US9458118B2Sodium channel modulators for the treatment of pain and diabetesCHROMOCELL CORP·Filed 2016·Granted Oct 4, 2016·3 cites·18 claims
- 0378US2023382896A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0478US2025171421A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0574US5888835AMethod and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technologyCHIRON DIAGNOSTICS CORP·Filed 1996·Granted Mar 30, 1999·38 cites·23 claims
- 0670US10934277B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Granted Mar 2, 2021·0 cites·11 claims
- 0766US11760749B2Enantiomerically purified GPER agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Granted Sep 19, 2023·0 cites·11 claims
- 0866US2022089576A1Enantiomerically purified gper agonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0961US2020024262A1Enantiomerically purified gper angonist for use in treating disease states and conditionsLINNAEUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1054US5257983ABlood bag for lyophilizationCRYOPHARM CORP·Filed 1991·Granted Nov 2, 1993·101 cites·4 claims
- 1154US2016221974A1Sodium channel modulators for the treatment of pain and diabetesCHROMOCELL CORP·Filed 2014·Application pending·0 cites
- 1254US2024376547A1Oncologic variations associated with cancer and methods of treatmentLINNAEUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1352US2024245674A1Diagnostic methods and compositions for treatment of cancerLINNAEUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1450US2016123959A1Methods and materials using signaling probesCHROMOCELL CORP·Filed 2014·Application pending·0 cites
- 1548US2013323726A1Methods and materials using signaling probesCHROMOCELL CORP·Filed 2013·Application pending·0 cites
- 1637US2010248224A1Dna fragmentation assaySANOFI AVENTIS·Filed 2007·Application pending·0 cites
- 1735US2004018615A1Virtual wells for use in high throughput screening assaysFiled 2003·Application pending·0 cites
- 1834US2017304306A1SELECTIVE NaV1.7 INHIBITORS FOR THE TREATMENT OF DIABETESCHROMOCELL CORP·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →